VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Human Immunome Program

Completed

Conditions: Healthy

First Posted Date: 2017-04-18

Last Posted Date: 2021-02-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2

Registration Number: NCT03118687

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Norepinephrine-targeted Therapy for Action Control in Parkinson Disease

Phase 4

Completed

Conditions: Parkinson Disease

Interventions: Drug: Droxidopa
Drug: Carbidopa

First Posted Date: 2017-04-14

Last Posted Date: 2020-01-27

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 15

Registration Number: NCT03115827

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Measuring Outcomes of Activity in Intensive Care

Active, not recruiting

Conditions: Mechanical Ventilation
Physical Activity
Disability Physical
Muscle Weakness
Critical Illness
Sepsis
Cognitive Impairment

First Posted Date: 2017-04-14

Last Posted Date: 2025-01-28

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 312

Registration Number: NCT03115840

Locations: 🇺🇸
The Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

The Effects of Renin Inhibition on Fibrinolytic Balance and Endothelial Function

Phase 4

Completed

Conditions: High Blood Pressure

Interventions: Drug: Aliskiren 150 mg
Drug: Placebo
Drug: HCTZ
Drug: Aliskiren 300 mg

First Posted Date: 2017-04-14

Last Posted Date: 2017-08-25

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 31

Registration Number: NCT03115853

Locations: 🇺🇸
VUMC, Nashville, Tennessee, United States

Preventing Tobacco Relapse With Omega-3s Trial

Not Applicable

Withdrawn

Conditions: Tobacco Dependence

Interventions: Dietary Supplement: Fish Oil
Dietary Supplement: Placebo

First Posted Date: 2017-04-13

Last Posted Date: 2017-11-06

Lead Sponsor: Vanderbilt University Medical Center

Registration Number: NCT03113370

Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms

Not Applicable

Terminated

Conditions: Thoracoabdominal Aortic Aneurysm

Interventions: Device: Thoracoabdominal Aortic Aneurysm Repair

First Posted Date: 2017-04-13

Last Posted Date: 2022-11-08

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 4

Registration Number: NCT03113383

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device

Conditions: Gastro Esophageal Reflux

Interventions: Diagnostic Test: single catheter mucosal impedance testing
Diagnostic Test: balloon assembly mucosal impedance testing

First Posted Date: 2017-04-06

Last Posted Date: 2025-05-21

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 75

Registration Number: NCT03103789

Locations: 🇺🇸
Vanderbilt University Medical Center Endoscopy Laboratory, Nashville, Tennessee, United States

Cardiovascular Effects of GLP-1 Receptor Activation

Phase 4

Completed

Conditions: Obesity
PreDiabetes

Interventions: Other: hypocaloric diet
Drug: Liraglutide
Drug: Sitagliptin
Drug: Placebos
Drug: Exendin (9-39)

First Posted Date: 2017-04-05

Last Posted Date: 2022-10-18

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 329

Registration Number: NCT03101930

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Cholinesterase Activity and DeliriUm During Critical Illness Study

Completed

Conditions: Cognitive Impairment
Delirium

First Posted Date: 2017-03-31

Last Posted Date: 2022-03-11

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 279

Registration Number: NCT03098472

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Illuminating Neuropsychological Dysfunction and Systemic Inflammatory Mechanisms Gleaned After Hospitalization in Trauma-ICU Study

Active, not recruiting

Conditions: Traumatic Brain Injury
Cognitive Impairment
Trauma
Polytrauma
ICU
Critical Illness
Delirium
Alzheimer; Early Onset

Interventions: Other: Non-interventional observational prospective cohort study

First Posted Date: 2017-03-31

Last Posted Date: 2024-11-07

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 432

Registration Number: NCT03098459

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy